Announcement of Fujian Aonong Biotechnology Group Co., Ltd. on receiving an information disclosure regulatory inquiry letter from the Shanghai Stock Exchange on the company's 2023 annual report

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.